About Ovarian Cancer
Ovarian cancer is rare but deadly1
A Diagnosis of Advanced-Stage Ovarian Cancer Often Leads to Poor Prognosis2
Despite optimal surgical outcomes and high response rates to 1L platinum-based chemotherapy, the outlook in advanced ovarian cancer remains poor3,4


Without maintenance, PFS shortens with each recurrence5
There is a need for a maintenance therapy that3,6-8

PROLONGS
progression-free survival

EXTENDS
PARP inhibitor therapy to more women9-11

Offers
CONVENIENT
once-daily, oral dosing
1L, first-line; BRCA, breast cancer susceptibility gene; CI, confidence interval; PARP, poly (ADP-ribose) polymerase; PFS, progression-free survival.
1L, first-line; BRCA, breast cancer susceptibility gene; CI, confidence interval; PARP, poly (ADP-ribose) polymerase; PFS, progression-free survival.